Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference
April 20, 2023?- Eupraxia Pharmaceuticals Inc.?("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced?that it will deliver a corporate presentation at the 2023 Bloom Burton & Co. Healthcare Investor Conference in Toronto.
Eupraxia?CEO Dr. James Helliwell will present on Tuesday, April 25th, 2023, at 10:30 a.m. ET at the Metro Toronto Convention Centre, and will participate in investor meetings at the conference on April 25th and 26th.?
Interested parties can access the presentation through the following link:??